SCHEMBL31074205

SCHEMBL31074205

OCC[C@H](O)c1cccc(F)c1F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.46
CES1 P23141 4/20 0.46
ADRA2A P08913 2/20 0.41
ADRA2B P18089 2/20 0.41
ADRA2C P18825 2/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
BCHE P06276 1/20 0.35
GLS O94925 1/20 0.35
ADRA1A P35348 1/20 0.34
ADRB2 P07550 1/20 0.34
ADRA1B P35368 1/20 0.34
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
ROCK2 O75116 1/20 0.31
ROCK1 Q13464 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3186857 0.84 CES2 (0.43) CES2CES1CYP3A4
SCHEMBL10091381 0.83 CES2 (0.45) CES2CES1ADRA2AADRA2BADRA2C
SCHEMBL7786189 0.81 CES2 (0.44) CES2CES1ADRA2AADRA2BADRA2C
SCHEMBL20943296 0.81 CFD (0.46) ADRA2AADRA2BADRA2CADRB1ADRB3
SCHEMBL30446181 0.81 CFD (0.46) ADRA2AADRA2BADRA2CADRB1ADRB3
SCHEMBL20943298 0.81 CFD (0.46) ADRA2AADRA2BADRA2CADRB1ADRB3
SCHEMBL8746393 0.80 CES2 (0.42) CES2CES1ADRA2AADRA2BADRA2C
SCHEMBL7153251 0.80 ADRA2C (0.53) CES2CES1ADRA2AADRA2BADRA2C
SCHEMBL3383956 0.79 CFD (0.44) CES2CES1BCHEGLS
SCHEMBL7523840 0.79 PPARG (0.42) CES2CES1ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024183772-A1 CYCLIC PHOSPHATE COMPOUND AS DRUG FOR REGULATING CHOLESTEROL METABOLISM VIA LIVER DELIVERY AND USE 浙江柏拉阿图医药科技有限公司 2024-09-12 WO disclosed